Mechanistically, it acts as a non-selective agonist of the melanocortin receptors, with reported activity at MC1R, MC3R, and MC4R
Tesamorelin directly activates receptors in the pituitary gland, leading to an increase in growth hormone release
This aids in protecting skin cells from damage, supporting structural integrity and helping slow visible signs of premature ageing
conducted a study involving 283 patients receiving GLP-1 RAs treatment, of whom 35 reported experiencing hair loss (androgenetic alopecia, telogen effluvium, unspecified hair loss)
It does so by reducing melanin production through the inhibition of the enzyme tyrosinase, and by converting eumelanin (dark pigment) into pheomelanin (a lighter, reddish-yellow pigment)
Klinic's seamless consultation process provides clear answers and access to this effective weight loss solution